Pharming Group
PHAR
3 hedge funds and large institutions have $166K invested in Pharming Group in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0% → 0% (-0%)
25% less funds holding
Funds holding: 4 → 3 (-1)
33% less capital invested
Capital invested by funds: $249K → $166K (-$83K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
+$75.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$164K |
| 2 |
Morgan Stanley
New York
|
-$425 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CPA
1
Cowen Prime Advisors
New York
| $132K | +$75.3K | +8,500 | +135% |
|
|
2
Morgan Stanley
New York
| $22K | -$425 | -48 | -2% |
|
|
3
UBS Group
Zurich,
Switzerland
| $12K | +$10.8K | +1,214 | +1,065% |
|
|
4
Jane Street
New York
| – | -$164K | -17,441 | Closed |
|
PHAR Hedge Fund Activity: Q4 2021 in Review
3 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q4 2021, worth a combined $166K — down 33% from $249K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PHAR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Cowen Prime Advisors, adding an estimated $75.3K. The largest seller was Jane Street, exiting entirely with an estimated $164K sold.
- 3 institutional investors held Pharming Group (PHAR) as of Q4 2021, down from 4 in Q3 2021.
- Funds reported $166K of Pharming Group stock for Q4 2021, down 33% quarter-over-quarter.
- 0 funds opened new Pharming Group positions in Q4 2021 and 1 closed out, a net change of -1 holder.
- The largest Pharming Group buyer in Q4 2021 was Cowen Prime Advisors, an estimated $75.3K added.
- The largest Pharming Group seller in Q4 2021 was Jane Street, an estimated $164K sold.
Based on aggregated 13F filings for Q4 2021.